SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/26/23 Magellan Health Inc. SC 13G/A 1:67K Evolent Health, Inc. Broadridge Fin’l So… Inc Centene Corp. |
Document/Exhibit Description Pages Size 1: SC 13G/A Amendment to Statement of Acquisition of HTML 66K Beneficial Ownership by a "Passive" Investor
☐ |
Rule 13d-1(b)
|
☑ |
Rule 13d-1(c)
|
☐ |
Rule 13d-1(d)
|
* |
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the
disclosure provided in a prior cover page.
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Magellan Health, Inc.
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
(a)☐
|
|||||
(b)☐
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Delaware
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
0
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
0%
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
CO
|
|
|
|||
|
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Centene Corporation
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
(a)☐
|
|||||
(b)☐
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Delaware
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
0
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
0%
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
CO
|
|
|
|||
|
|
Item 1(a) |
Name of Issuer
|
Item 1(b) |
Address of Issuer’s Principal Executive Offices
|
Item 2(a) |
Name of Person Filing
|
(i) |
Magellan Health, Inc., a Delaware corporation; and
|
(ii) |
Centene Corporation, a Delaware corporation, which is the holder of all of the issued and outstanding shares of Magellan Health, Inc.
|
Item 2(b) |
Address of Principal Business Office or, if None, Residence
|
Item 2(c) |
Citizenship
|
Item 2(d) |
Title of Class of Securities
|
Item 2(e) |
CUSIP No.
|
Item 3. |
If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:
|
(a) |
☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
(b) |
☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
(c) |
☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
|
(d) |
☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
(e) |
☐ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
|
(f) |
☐ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
|
(g) |
☐ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
|
(h) |
☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
|
(i) |
☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
|
(j) |
☐ Group, in accordance with §240.13d-1(b)(1)(ii)(J).
|
Item 4. |
Ownership
|
(a) |
Amount Beneficially Owned: See Item 9 of each of the cover pages.
|
(b) |
Percent of Class: See Item 11 of each of the cover pages.
|
(c) |
Number of Shares as to which such person has:
|
(i) |
Sole power to vote or direct the vote: See Item 5 of each of the cover pages.
|
(ii) |
Shared power to vote or direct the vote: See Item 6 of each of the cover pages.
|
(iii) |
Sole power to dispose or direct the disposition: See Item 7 of each of the cover pages.
|
(iv) |
Shared power to dispose or direct the disposition: See Item 8 of each of the cover pages.
|
Item 5. |
Ownership of Five Percent or Less of a Class
|
Item 6. |
Ownership of More Than Five Percent on Behalf of Another Person
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
|
Item 8. |
Identification and Classification of Members of the Group
|
Item 9. |
Notice of Dissolution of Group
|
Item 10. |
Certification
|
Dated: April 26, 2023 | |||
MAGELLAN HEALTH, INC.
|
|||
By:
|
/s/ Derrick Duke
|
||
|
Name: | Derrick Duke | |
|
Title: | Chief Executive Officer | |
CENTENE CORPORATION
|
|||
By:
|
|||
|
Name: | Christopher A. Koster | |
|
Title:
|
Executive Vice President, General Counsel and Secretary |
This ‘SC 13G/A’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 4/26/23 | |||
4/6/23 | ||||
1/27/23 | SC 13G | |||
List all Filings |